According to a recent LinkedIn post from Artera, the company’s AI Agents have been deployed by Atlantic Health to improve outreach for colonoscopy appointments. The post indicates that this use case targets a historically manual and resource-intensive workflow that has contributed to screening gaps, cancellations, and no-shows.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights early performance metrics from the first 30 days of the deployment. According to the figures shared, 43% of contacted patients successfully answered and confirmed their identities, while 39% explicitly confirmed attendance for upcoming procedures.
The post also cites a 38% reduction in staff time spent on manual outreach calls, suggesting potential labor-cost efficiencies for provider organizations. If such results prove durable and scalable across customers, Artera could strengthen its value proposition in automating high-friction, compliance-sensitive patient engagement workflows.
For investors, the described collaboration with Atlantic Health may signal growing healthcare adoption of AI-driven communication tools in specialty care pathways such as colonoscopy screening. Demonstrated operational benefits in this setting could support Artera’s ability to expand within existing accounts, win new health system clients, and potentially command premium pricing for outcomes-oriented solutions.
The reference to external coverage in Becker’s Healthcare suggests an effort to build third-party validation and industry visibility. Increased exposure in sector-specific media could help Artera position itself among leading patient engagement and workflow automation vendors as health systems look to offset staffing constraints and improve utilization of scheduled procedures.